Status:
TERMINATED
A Study of MK0364 in Obese Patients (0364-014)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A worldwide study in obese patients to assess the efficacy, safety, and tolerability of an investigational drug.
Eligibility Criteria
Inclusion
- Body Mass Index (BMI) between 30-43 kg/m2
Exclusion
- History of major psychiatric disorder
- History of seizures or at high risk of developing seizures
- Blood pressure greater than 160/100
- Fasting blood glucose greater than 126 mg/dL
- Triglycerides greater than 600 mg/dL
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT00131391
Start Date
July 1 2005
End Date
December 1 2008
Last Update
April 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.